TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Swedish Orphan Biovitrum International AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,096
|
2,150
|
2,294 |
Financial expenses |
8,353
|
8,834
|
9,542 |
Earnings before taxes |
-5,869
|
-8,581
|
-14,578 |
EBITDA |
1,976
|
118
|
-2,987 |
Total assets |
508,179
|
539,878
|
565,865 |
Current assets |
3,105
|
37,941
|
18,535 |
Current liabilities |
9,304
|
1,339
|
1,588 |
Equity capital |
125,835
|
110,937
|
105,281 |
- share capital |
56
![]() |
56
|
61 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.8%
|
20.5%
|
18.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-280.0%
|
-399.1%
|
-635.5% |
Return on assets (ROA) |
0.5%
|
0.0%
|
-0.9% |
Current ratio |
33.4%
|
2833.5%
|
1167.2% |
Return on equity (ROE) |
-4.7%
|
-7.7%
|
-13.8% |
Change turnover |
-60
|
42
|
-1,027 |
Change turnover % |
-3%
|
2%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.